iBio Inc (NASDAQ: IBIO) is -66.03% lower on its value in year-to-date trading and has touched a low of $0.64 and a high of $6.89 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IBIO stock was last observed hovering at around $0.73 in the last trading session, with the day’s gains setting it 1.86%.
Currently trading at $2.59M, the stock is -17.24% and -17.71% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.43 million and changing 2426607% at the moment leaves the stock -71.26% off its SMA200. IBIO registered -71.02% loss for a year compared to 6-month loss of -71.37%. The firm has a 50-day simple moving average (SMA 50) of $0.8628 and a 200-day simple moving average (SMA200) of $2.4702.
The stock witnessed a -12.19% gain in the last 1 month and extending the period to 3 months gives it a -83.53%, and is -21.11% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 19.21% over the week and 12.88% over the month.
iBio Inc (IBIO) has around 19 employees, a market worth around $11.52M and $0.38M in sales. Profit margin for the company is -5597.87%. Distance from 52-week low is 11.67% and -89.70% from its 52-week high. The company has generated returns on investments over the last 12 months (-153.16%).
The EPS is expected to grow by 56.08% this year
38.0 institutions hold shares in iBio Inc (IBIO), with institutional investors hold 16.49% of the company’s shares. The shares outstanding are 16.22M, and float is at 15.30M with Short Float at 5.41%. Institutions hold 15.78% of the Float.
The top institutional shareholder in the company is LYNX1 CAPITAL MANAGEMENT LP with over 0.6 million shares valued at $1.27 billion. The investor’s holdings represent 6.9576 of the IBIO Shares outstanding. As of 2024-06-30, the second largest holder is IKARIAN CAPITAL, LLC with 0.6 million shares valued at $1.27 million to account for 6.9576 of the shares outstanding. The other top investors are ADAR1 CAPITAL MANAGEMENT, LLC which holds 0.57 million shares representing 6.6097 and valued at over $1.2 million, while OPALEYE MANAGEMENT INC. holds 4.3485 of the shares totaling 0.38 million with a market value of $0.79 million.
iBio Inc (IBIO) Insider Activity
The most recent transaction is an insider purchase by Duran Felipe, the company’s Chief Financial Officer. SEC filings show that Duran Felipe bought 9,191 shares of the company’s common stock on Jan 10 ’25 at a price of $2.72 per share for a total of $25000.0. Following the purchase, the insider now owns 11139.0 shares.
iBio Inc disclosed in a document filed with the SEC on Jan 10 ’25 that Brenner Martin bought a total of 9,191 shares of the company’s common stock. The trade occurred on Jan 10 ’25 and was made at $2.72 per share for $25000.0. Following the transaction, the insider now directly holds 18316.0 shares of the IBIO stock.
Still, SEC filings show that on Jan 10 ’25, Banjak Marc (Chief Legal Officer) acquired 9,191 shares at an average price of $2.72 for $25000.0. The insider now directly holds 11,066 shares of iBio Inc (IBIO).
